Previous Post: Worldwatch publishes ‘State of World’ report nbsp Next Post: Iran-fueled oil price spike biggest threat to economy
Johnson Johnson fined $1.1bn in latest Risperdal case
BBC – Drugs giant Johnson Johnson (JJ) has been ordered by a US judge to pay $1.1bn (£690m) for downplaying the risks involved in taking its anti-psychotic drug Risperdal. The state of Arkansas sued JJ and its subsidiary Janssen Pharmaceuticals over its marketing of the drug in 2007. A number of US states have already found the firms guilty of similar charges and fined them accordingly. Read Article
Tags: crime law, nature of corporations, North America, pharmaceuticals
Related posts:
Views: 0